TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
The TAXUS ARRIVE 2 study is a multi-center safety and surveillance study designed to to
 compile safety surveillance and clinical outcomes data for the TAXUS™ Express2™
 Paclitaxel-Eluting Coronary Stent System in routine clinical practice and to identify low
 frequency TAXUS related clinical events.
Appropriate Patient Criteria:

 -  Patient is eligible to receive a Boston Scientific TAXUS Stent

 Inappropriate Patient Criteria:

 -  Known sensitivity to paclitaxel.

 -  Known allergy to stainless steel.

 -  Patients in whom antiplatelet and / or anticoagulant therapy is contraindicated.

 -  Patients judged to have a lesion that prevents complete inflation of an angioplasty
 balloon or proper placement of the stent or delivery device.

 -  Patients with unresolved vessel thrombus at the lesion site.

 -  Patients with coronary artery reference vessel diameters less than 2.5 mm or greater
 than 3.75 mm.

 -  Patients with lesions located in the left main coronary artery, ostial lesions, or
 lesions located at a bifurcation.

 -  Patients with diffuse disease or poor overflow distal to the identified lesions.

 -  Patients with tortuous vessels in the region of the obstruction or proximal to the
 lesion.

 -  Patients with a recent acute myocardial infarction where there is evidence of thrombus
 or poor flow.